Tag: eczema

UV Light Linked to Prevention of Allergic Disease in Infants

Higher direct ultraviolet (UV) light exposure in the first 3 months of life was linked to lower incidence of proinflammatory immune markers and lower incidence...

Dupilumab Safe, Effective in Kids With Moderate-to-Severe Asthma

Dupilumab (Dupixent, Sanofi and Regeneron) significantly reduced exacerbations compared with placebo in children ages 6-11 years who had moderate-to-severe asthma in a phase 3 trial....

Expert Shares Practical Considerations for Dupilumab Treatment

Clinicians who struggle to get dupilumab approved for their patients with moderate to severe atopic dermatitis (AD) are not alone. This scenario was illustrated in...

Eczema and Your Diet

Up to 6% of adults have atopic dermatitis, a chronic, severe form of eczema that causes skin to become dry, red, itchy, and cracked. If...

Emollient Data Discouraging for Atopic Dermatitis Prevention

Emollients don’t prevent atopic dermatitis (AD), but they might have untapped potential as treatment, two new studies suggest. The results of a prevention study, in...

Multidisciplinary Approach Touted for Atopic Dermatitis

Bringing pharmacists, allergists, and dermatologists together to discuss patient care can improve outcomes for children with atopic dermatitis, researchers say. “I think we really gained...

Novel S1P-Receptor Modulator Shows Promise in Phase 2b AD Trial

A novel, highly selective oral sphingosine 1-phosphate (S1P)–receptor modulator showed promise as a treatment for atopic dermatitis (AD) in a 12-week phase 2b trial, according...

Tralokinumab Gets Nod for Atopic Dermatitis in Europe

On Friday, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion for the IL-13 inhibitor...

Severe Eczema: How to Manage It

Ashley Hall has been living with severe eczema for more than 3 decades. She was only 2 years old when the first patch of dry,...

Keeping a Positive Body Image

Gabby Bachner, a pharmacy student at the University of Georgia in Athens, found out she had eczema soon after she went to college. The...

Curbing Itch Intensity, Frequency in Children With Severe Eczema

Dupilumab treatment with concomitant topical corticosteroids provided rapid and sustained improvement in itch intensity and frequency in children aged 6-11 years with severe atopic dermatitis....

Improvements in Chronic Hand Eczema Seen With Oral Gusacitinib

Gusacitinib, a novel oral inhibitor of multiple inflammatory pathways, achieved rapid and clinically meaningful improvement in corticosteroid-refractory moderate to severe chronic hand eczema in a...

Delgocitinib Successful for Hand Eczema in Phase 2b Trial

Delgocitinib cream shows a dose-dependent response in easing chronic hand eczema, a common and difficult-to-treat disorder for which few other topical options are available, new...

Even a Few Days of Steroids May Be Risky, New Study Suggests

Extended use of corticosteroids for chronic inflammatory conditions puts patients at risk for serious adverse events (AEs), including cardiovascular disease, osteoporosis, cataracts, and diabetes. Now,...

COMMENTARY: Dermatologist First, Businessman Second: Life During COVID-19

What your doctor is reading on Medscape.com: APRIL 15, 2020 — Monday 8:00 AM. Standing in the Stop & Shop parking lot,...